Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response

Metformin, a biguanide agent, is the first-line treatment for type 2 diabetes mellitus due to its glucose-lowering effect. Despite its wide application in the treatment of multiple health conditions, the glycemic response to metformin is highly variable, emphasizing the need for reliable biomarkers....

Descripción completa

Detalles Bibliográficos
Autores principales: Ustinova, Monta, Ansone, Laura, Silamikelis, Ivars, Rovite, Vita, Elbere, Ilze, Silamikele, Laila, Kalnina, Ineta, Fridmanis, Davids, Sokolovska, Jelizaveta, Konrade, Ilze, Pirags, Valdis, Klovins, Janis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418999/
https://www.ncbi.nlm.nih.gov/pubmed/32780768
http://dx.doi.org/10.1371/journal.pone.0237400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418999/
https://www.ncbi.nlm.nih.gov/pubmed/32780768
http://dx.doi.org/10.1371/journal.pone.0237400

Ejemplares similares